{"transactions":[{"id":4627644,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-09-28T20:30:10.000Z","date":"2026-09-24","kind":"gift","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Custodial Account for Child"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian."}],"balance_after":20571,"source":{"system":"sec-edgar","filing":"0001193125-26-405402","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1529655/000119312526405402/ownership.xml","form_type":"4"}},{"id":4627643,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-09-28T20:30:10.000Z","date":"2026-09-24","kind":"gift","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Custodial Account for Child"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian."}],"balance_after":20571,"source":{"system":"sec-edgar","filing":"0001193125-26-405402","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1529655/000119312526405402/ownership.xml","form_type":"4"}},{"id":4627642,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-09-28T20:30:10.000Z","date":"2026-09-24","kind":"gift","planned":false,"acquired":false,"shares":17100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 776 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 164 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":14056,"source":{"system":"sec-edgar","filing":"0001193125-26-405402","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1529655/000119312526405402/ownership.xml","form_type":"4"}},{"id":4622942,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-09-18T23:47:51.000Z","date":"2026-09-17","kind":"exercise","planned":false,"acquired":false,"shares":17493,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."}],"balance_after":182507,"derivative":{"exercise_price":8.27,"expiration_date":"2027-02-10","underlying":"Common Stock","underlying_shares":17493},"source":{"system":"sec-edgar","filing":"0001193125-26-395827","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1529655/000119312526395827/ownership.xml","form_type":"4"}},{"id":4622941,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-09-18T23:47:51.000Z","date":"2026-09-17","kind":"exercise","planned":false,"acquired":true,"shares":17493,"price":8.27,"value":144667.11,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 776 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 164 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":31156,"source":{"system":"sec-edgar","filing":"0001193125-26-395827","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1529655/000119312526395827/ownership.xml","form_type":"4"}},{"id":3987,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-09-04T01:03:08.000Z","date":"2026-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":91,"price":113.38,"value":10317.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The closing price on September 1, 2026 was used to calculate the withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 776 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":13663,"source":{"system":"sec-edgar","filing":"0001193125-26-382457","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1529655/000119312526382457/ownership.xml","form_type":"4"}},{"id":3986,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-09-04T01:03:08.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 776 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":13754,"source":{"system":"sec-edgar","filing":"0001193125-26-382457","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1529655/000119312526382457/ownership.xml","form_type":"4"}},{"id":3985,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-09-04T01:03:08.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":164,"price":113.38,"value":18594.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on September 1, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 776 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":13590,"source":{"system":"sec-edgar","filing":"0001193125-26-382457","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1529655/000119312526382457/ownership.xml","form_type":"4"}},{"id":684289,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-08-18T20:30:06.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":116.2572,"value":1162572.0,"ownership":{"direct":false,"nature":"Gary Charles Robb TTE Robb Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.00 to $116.54 per share. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Gary Charles Robb TTE Robb Revocable Trust of which the Reporting Person is trustee."}],"balance_after":39716,"source":{"system":"sec-edgar","filing":"0001193125-26-355560","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526355560/ownership.xml","form_type":"4"}},{"id":684288,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-08-18T20:30:06.000Z","date":"2026-08-17","kind":"gift","planned":false,"acquired":false,"shares":125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 776 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":13426,"source":{"system":"sec-edgar","filing":"0001193125-26-355560","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526355560/ownership.xml","form_type":"4"}},{"id":687276,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-08-14T20:31:37.000Z","date":"2026-08-12","kind":"gift","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Custodial Account for Child"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian."}],"balance_after":15571,"source":{"system":"sec-edgar","filing":"0001193125-26-352428","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526352428/ownership.xml","form_type":"4"}},{"id":687275,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-08-14T20:31:37.000Z","date":"2026-08-12","kind":"gift","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Custodial Account for Child"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian."}],"balance_after":15571,"source":{"system":"sec-edgar","filing":"0001193125-26-352428","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526352428/ownership.xml","form_type":"4"}},{"id":687274,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-08-14T20:31:37.000Z","date":"2026-08-12","kind":"gift","planned":false,"acquired":false,"shares":11530,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 776 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":13551,"source":{"system":"sec-edgar","filing":"0001193125-26-352428","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526352428/ownership.xml","form_type":"4"}},{"id":713079,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-07-09T00:01:14.000Z","date":"2026-05-27","kind":"gift","planned":false,"acquired":false,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 776 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":25081,"source":{"system":"sec-edgar","filing":"0001193125-26-298871","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526298871/ownership.xml","form_type":"4"}},{"id":752859,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-06-03T23:15:19.000Z","date":"2026-06-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":358,"price":70.44,"value":25217.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The closing price on June 1, 2026 was used to calculate the withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, and 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":25681,"source":{"system":"sec-edgar","filing":"0001193125-26-256002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526256002/ownership.xml","form_type":"4"}},{"id":752858,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-06-03T23:15:19.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":776,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, and 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":26039,"source":{"system":"sec-edgar","filing":"0001193125-26-256002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526256002/ownership.xml","form_type":"4"}},{"id":752857,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-06-03T23:15:19.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":776,"price":70.44,"value":54661.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on June 1, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, and 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":25263,"source":{"system":"sec-edgar","filing":"0001193125-26-256002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526256002/ownership.xml","form_type":"4"}},{"id":777705,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-05-15T22:59:21.000Z","date":"2026-05-13","kind":"gift","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Custodial Account for Child"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian."}],"balance_after":12571,"source":{"system":"sec-edgar","filing":"0001193125-26-227411","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526227411/ownership.xml","form_type":"4"}},{"id":777704,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-05-15T22:59:21.000Z","date":"2026-05-13","kind":"gift","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Custodial Account for Child"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian."}],"balance_after":12571,"source":{"system":"sec-edgar","filing":"0001193125-26-227411","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526227411/ownership.xml","form_type":"4"}},{"id":777703,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-05-15T22:59:21.000Z","date":"2026-05-13","kind":"gift","planned":false,"acquired":false,"shares":5300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, and 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Excludes 49,716 shares previously owned directly which were transferred to the Gary Charles Robb TTE Robb Revocable Trust."}],"balance_after":24487,"source":{"system":"sec-edgar","filing":"0001193125-26-227411","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526227411/ownership.xml","form_type":"4"}},{"id":863058,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-03-05T01:21:50.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":121,"price":35.97,"value":4352.37,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The closing price on March 2, 2026 was used to calculate the withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025,  and 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025 and 224 share underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":79503,"source":{"system":"sec-edgar","filing":"0001193125-26-092158","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526092158/ownership.xml","form_type":"4"}},{"id":863057,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-03-05T01:21:50.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":499,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025 and 224 share underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":79624,"source":{"system":"sec-edgar","filing":"0001193125-26-092158","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526092158/ownership.xml","form_type":"4"}},{"id":863056,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-03-05T01:21:50.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":499,"price":35.97,"value":17949.03,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on March 2, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025 and 224 share underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":79125,"source":{"system":"sec-edgar","filing":"0001193125-26-092158","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526092158/ownership.xml","form_type":"4"}},{"id":870153,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-03T23:13:55.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercise ratably in equal installments on each monthly anniversary of February 27, 2026 over a four-year period subject to the Reporting Person's continued service through each vesting date."}],"balance_after":140000,"derivative":{"exercise_price":35.7,"expiration_date":"2036-02-27","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001193125-26-089010","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526089010/ownership.xml","form_type":"4"}},{"id":958843,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-12-29T22:58:55.000Z","date":"2025-12-24","kind":"exercise","planned":false,"acquired":false,"shares":145000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":3.88,"expiration_date":"2026-02-26","underlying":"Common Stock","underlying_shares":145000},"source":{"system":"sec-edgar","filing":"0001193125-25-335575","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525335575/ownership.xml","form_type":"4"}},{"id":958842,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-12-29T22:58:55.000Z","date":"2025-12-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":80284,"price":83.59,"value":6710939.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability from a net (cashless) exercise of options."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, and 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":78626,"source":{"system":"sec-edgar","filing":"0001193125-25-335575","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525335575/ownership.xml","form_type":"4"}},{"id":958841,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-12-29T22:58:55.000Z","date":"2025-12-24","kind":"exercise","planned":false,"acquired":true,"shares":145000,"price":3.88,"value":562600.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, and 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":158910,"source":{"system":"sec-edgar","filing":"0001193125-25-335575","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525335575/ownership.xml","form_type":"4"}},{"id":982391,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-12-04T01:22:28.000Z","date":"2025-12-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":148,"price":79.78,"value":11807.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The closing price on December 1, 2025 was used to calculate the withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025 and 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":13910,"source":{"system":"sec-edgar","filing":"0001193125-25-307213","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525307213/ownership.xml","form_type":"4"}},{"id":982390,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-12-04T01:22:28.000Z","date":"2025-12-01","kind":"grant","planned":false,"acquired":true,"shares":224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025 and 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":14058,"source":{"system":"sec-edgar","filing":"0001193125-25-307213","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525307213/ownership.xml","form_type":"4"}},{"id":982389,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-12-04T01:22:28.000Z","date":"2025-12-01","kind":"grant","planned":false,"acquired":true,"shares":224,"price":79.78,"value":17870.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on December 1, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025 and 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":13834,"source":{"system":"sec-edgar","filing":"0001193125-25-307213","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525307213/ownership.xml","form_type":"4"}},{"id":1048516,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-09-04T23:51:01.000Z","date":"2025-09-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":256,"price":71.38,"value":18273.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The closing price on September 2, 2025 was used to calculate the withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025 and 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":13610,"source":{"system":"sec-edgar","filing":"0001193125-25-196309","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525196309/ownership.xml","form_type":"4"}},{"id":1048515,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-09-04T23:51:01.000Z","date":"2025-09-02","kind":"grant","planned":false,"acquired":true,"shares":251,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025 and 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":13866,"source":{"system":"sec-edgar","filing":"0001193125-25-196309","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525196309/ownership.xml","form_type":"4"}},{"id":1048514,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-09-04T23:51:01.000Z","date":"2025-09-02","kind":"grant","planned":false,"acquired":true,"shares":251,"price":71.38,"value":17916.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on September 2, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025 and 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":13615,"source":{"system":"sec-edgar","filing":"0001193125-25-196309","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525196309/ownership.xml","form_type":"4"}},{"id":1056087,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-08-26T22:56:08.000Z","date":"2025-08-22","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."}],"balance_after":145000,"derivative":{"exercise_price":3.88,"expiration_date":"2026-02-26","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001193125-25-188869","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525188869/ownership.xml","form_type":"4"}},{"id":1056086,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-08-26T22:56:08.000Z","date":"2025-08-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":2674,"price":71.17,"value":190308.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability from a net (cashless) exercise of options."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025 and 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":13364,"source":{"system":"sec-edgar","filing":"0001193125-25-188869","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525188869/ownership.xml","form_type":"4"}},{"id":1056085,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-08-26T22:56:08.000Z","date":"2025-08-22","kind":"sale","planned":false,"acquired":false,"shares":2326,"price":71.27,"value":165774.02,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025 and 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":16038,"source":{"system":"sec-edgar","filing":"0001193125-25-188869","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525188869/ownership.xml","form_type":"4"}},{"id":1056084,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-08-26T22:56:08.000Z","date":"2025-08-22","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":3.88,"value":19400.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025 and 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":18364,"source":{"system":"sec-edgar","filing":"0001193125-25-188869","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525188869/ownership.xml","form_type":"4"}},{"id":1106801,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-06-18T22:26:15.000Z","date":"2025-06-16","kind":"sale","planned":false,"acquired":false,"shares":3185,"price":70.77,"value":225402.45,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025 and 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":13364,"source":{"system":"sec-edgar","filing":"0000950170-25-088005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025088005/ownership.xml","form_type":"4"}},{"id":1123579,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-06-05T00:32:50.000Z","date":"2025-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":651,"price":71.68,"value":46663.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The closing price on June 2, 2025 was used to calculate the withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024 and 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":16549,"source":{"system":"sec-edgar","filing":"0000950170-25-081932","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025081932/ownership.xml","form_type":"4"}},{"id":1123578,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-06-05T00:32:50.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":997,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024 and 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":17200,"source":{"system":"sec-edgar","filing":"0000950170-25-081932","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025081932/ownership.xml","form_type":"4"}},{"id":1123577,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-06-05T00:32:50.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":997,"price":71.68,"value":71464.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on June 2, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024 and 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":16203,"source":{"system":"sec-edgar","filing":"0000950170-25-081932","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025081932/ownership.xml","form_type":"4"}},{"id":1137930,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-05-22T20:48:38.000Z","date":"2025-05-20","kind":"gift","planned":false,"acquired":true,"shares":360,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Custodial Account for Child"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian."}],"balance_after":11571,"source":{"system":"sec-edgar","filing":"0000950170-25-076417","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025076417/ownership.xml","form_type":"4"}},{"id":1137929,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-05-22T20:48:38.000Z","date":"2025-05-20","kind":"gift","planned":false,"acquired":true,"shares":360,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Custodial Account for Child"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian."}],"balance_after":11571,"source":{"system":"sec-edgar","filing":"0000950170-25-076417","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025076417/ownership.xml","form_type":"4"}},{"id":1137928,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-05-22T20:48:38.000Z","date":"2025-05-20","kind":"gift","planned":false,"acquired":false,"shares":1380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024, 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024 and 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":15206,"source":{"system":"sec-edgar","filing":"0000950170-25-076417","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025076417/ownership.xml","form_type":"4"}},{"id":1137927,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-05-22T20:48:38.000Z","date":"2025-05-20","kind":"sale","planned":false,"acquired":false,"shares":2279,"price":75.85,"value":172862.15,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024, 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024 and 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":16586,"source":{"system":"sec-edgar","filing":"0000950170-25-076417","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025076417/ownership.xml","form_type":"4"}},{"id":1167299,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-04-23T23:41:27.000Z","date":"2025-01-27","kind":"gift","planned":false,"acquired":true,"shares":313,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Custodial Account for Child"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian."}],"balance_after":11211,"source":{"system":"sec-edgar","filing":"0000950170-25-057620","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025057620/ownership.xml","form_type":"4"}},{"id":1167298,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-04-23T23:41:27.000Z","date":"2025-01-27","kind":"gift","planned":false,"acquired":true,"shares":313,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Custodial Account for Child"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian."}],"balance_after":11211,"source":{"system":"sec-edgar","filing":"0000950170-25-057620","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025057620/ownership.xml","form_type":"4"}},{"id":1193955,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-03-25T00:30:38.000Z","date":"2025-03-20","kind":"gift","planned":false,"acquired":true,"shares":233,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Custodial Account for Child"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian."}],"balance_after":10898,"source":{"system":"sec-edgar","filing":"0000950170-25-044069","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025044069/ownership.xml","form_type":"4"}},{"id":1193954,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-03-25T00:30:38.000Z","date":"2025-03-20","kind":"gift","planned":false,"acquired":true,"shares":233,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Custodial Account for Child"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian."}],"balance_after":10898,"source":{"system":"sec-edgar","filing":"0000950170-25-044069","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025044069/ownership.xml","form_type":"4"}},{"id":1206419,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-03-14T21:30:26.000Z","date":"2025-03-12","kind":"gift","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Custodial Account for Child"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian."}],"balance_after":10665,"source":{"system":"sec-edgar","filing":"0000950170-25-039604","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025039604/ownership.xml","form_type":"4"}},{"id":1206418,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-03-14T21:30:26.000Z","date":"2025-03-12","kind":"gift","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Custodial Account for Child"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian."}],"balance_after":10665,"source":{"system":"sec-edgar","filing":"0000950170-25-039604","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025039604/ownership.xml","form_type":"4"}},{"id":1206417,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-03-14T21:30:26.000Z","date":"2025-03-12","kind":"gift","planned":false,"acquired":false,"shares":4625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024, 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024 and 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":18865,"source":{"system":"sec-edgar","filing":"0000950170-25-039604","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025039604/ownership.xml","form_type":"4"}},{"id":1231334,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-03-05T00:27:29.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Exercise ratably in equal installments on each monthly anniversary of February 28, 2025 over a four-year period subject to the Reporting Person's continued service through each vesting date."}],"balance_after":140000,"derivative":{"exercise_price":60.58,"expiration_date":"2035-02-28","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0000950170-25-032708","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025032708/ownership.xml","form_type":"4"}},{"id":1231333,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-03-05T00:27:29.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024, 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024 and 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":23490,"source":{"system":"sec-edgar","filing":"0000950170-25-032708","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025032708/ownership.xml","form_type":"4"}},{"id":1231332,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-03-05T00:27:29.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":292,"price":59.07,"value":17248.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on March 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024, 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024 and 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":23198,"source":{"system":"sec-edgar","filing":"0000950170-25-032708","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025032708/ownership.xml","form_type":"4"}},{"id":1231331,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-03-05T00:27:29.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":250,"price":60.58,"value":15145.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The closing price on February 28, 2025 was used to calculate the withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024, 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024 and 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":22906,"source":{"system":"sec-edgar","filing":"0000950170-25-032708","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025032708/ownership.xml","form_type":"4"}},{"id":1311670,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-01-07T00:15:43.000Z","date":"2025-01-03","kind":"exercise","planned":true,"acquired":false,"shares":3037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":3.29,"expiration_date":"2025-02-18","underlying":"Common Stock","underlying_shares":3037},"source":{"system":"sec-edgar","filing":"0000950170-25-002439","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025002439/ownership.xml","form_type":"4"}},{"id":1311669,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-01-07T00:15:43.000Z","date":"2025-01-02","kind":"exercise","planned":true,"acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."}],"balance_after":3037,"derivative":{"exercise_price":3.29,"expiration_date":"2025-02-18","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0000950170-25-002439","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025002439/ownership.xml","form_type":"4"}},{"id":1311668,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-01-07T00:15:43.000Z","date":"2025-01-03","kind":"exercise","planned":true,"acquired":true,"shares":3037,"price":3.29,"value":9991.73,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024, 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024 and 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":23156,"source":{"system":"sec-edgar","filing":"0000950170-25-002439","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025002439/ownership.xml","form_type":"4"}},{"id":1311667,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-01-07T00:15:43.000Z","date":"2025-01-02","kind":"sale","planned":true,"acquired":false,"shares":11000,"price":50.5047,"value":555551.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $50.39 to $50.84 per share. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024, 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024 and 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":20119,"source":{"system":"sec-edgar","filing":"0000950170-25-002439","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025002439/ownership.xml","form_type":"4"}},{"id":1311666,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-01-07T00:15:43.000Z","date":"2025-01-02","kind":"exercise","planned":true,"acquired":true,"shares":11000,"price":3.29,"value":36190.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024, 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024 and 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":31119,"source":{"system":"sec-edgar","filing":"0000950170-25-002439","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025002439/ownership.xml","form_type":"4"}},{"id":1343609,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-12-05T00:41:33.000Z","date":"2024-12-02","kind":"grant","planned":false,"acquired":true,"shares":290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024 and 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":20119,"source":{"system":"sec-edgar","filing":"0000950170-24-133440","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024133440/ownership.xml","form_type":"4"}},{"id":1343608,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-12-05T00:41:33.000Z","date":"2024-12-02","kind":"grant","planned":false,"acquired":true,"shares":290,"price":59.21,"value":17170.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on December 2, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024 and 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":19829,"source":{"system":"sec-edgar","filing":"0000950170-24-133440","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024133440/ownership.xml","form_type":"4"}},{"id":1343607,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-12-05T00:41:33.000Z","date":"2024-12-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":324,"price":57.68,"value":18688.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were withheld by the Issuer in order to satisfy certain withholding obligations in connection with the issuance of share upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The closing price on November 29, 2024 was used to calculate the withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024 and 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":19539,"source":{"system":"sec-edgar","filing":"0000950170-24-133440","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024133440/ownership.xml","form_type":"4"}},{"id":1351525,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-11-26T23:16:40.000Z","date":"2024-11-22","kind":"gift","planned":false,"acquired":false,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024 and 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":19863,"source":{"system":"sec-edgar","filing":"0000950170-24-131176","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024131176/ownership.xml","form_type":"4"}},{"id":1351524,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-11-26T23:16:40.000Z","date":"2024-11-22","kind":"sale","planned":false,"acquired":false,"shares":2609,"price":56.2,"value":146625.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024 and 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":20163,"source":{"system":"sec-edgar","filing":"0000950170-24-131176","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024131176/ownership.xml","form_type":"4"}},{"id":1397180,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock option (right to buy)","published_at":"2024-10-01T23:55:33.000Z","date":"2024-10-01","kind":"exercise","planned":true,"acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Full exercisable."}],"balance_after":14037,"derivative":{"exercise_price":3.29,"expiration_date":"2025-02-18","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0000950170-24-111052","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024111052/ownership.xml","form_type":"4"}},{"id":1397179,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-10-01T23:55:33.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":11000,"price":46.28,"value":509080.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024 and 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":22772,"source":{"system":"sec-edgar","filing":"0000950170-24-111052","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024111052/ownership.xml","form_type":"4"}},{"id":1397178,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-10-01T23:55:33.000Z","date":"2024-10-01","kind":"exercise","planned":true,"acquired":true,"shares":11000,"price":3.29,"value":36190.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024 and 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":33772,"source":{"system":"sec-edgar","filing":"0000950170-24-111052","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024111052/ownership.xml","form_type":"4"}},{"id":1397177,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-10-01T23:55:33.000Z","date":"2024-09-27","kind":"gift","planned":true,"acquired":true,"shares":415,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Custodial Account for Child"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian."}],"balance_after":9665,"source":{"system":"sec-edgar","filing":"0000950170-24-111052","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024111052/ownership.xml","form_type":"4"}},{"id":1397176,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-10-01T23:55:33.000Z","date":"2024-09-27","kind":"gift","planned":true,"acquired":true,"shares":415,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Custodial Account for Child"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian."}],"balance_after":9665,"source":{"system":"sec-edgar","filing":"0000950170-24-111052","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024111052/ownership.xml","form_type":"4"}},{"id":1402715,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-09-19T22:34:47.000Z","date":"2024-09-18","kind":"other","planned":false,"acquired":false,"shares":7250,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Custodial Account for Child"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were transferred from the custodial account to the child's personal account."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-108226","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024108226/ownership.xml","form_type":"4"}},{"id":1402714,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-09-19T22:34:47.000Z","date":"2024-09-18","kind":"gift","planned":false,"acquired":false,"shares":870,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024 and 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":22772,"source":{"system":"sec-edgar","filing":"0000950170-24-108226","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024108226/ownership.xml","form_type":"4"}},{"id":1402713,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-09-19T22:34:47.000Z","date":"2024-09-17","kind":"gift","planned":false,"acquired":false,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024 and 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":23642,"source":{"system":"sec-edgar","filing":"0000950170-24-108226","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024108226/ownership.xml","form_type":"4"}},{"id":1414464,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-09-05T23:57:22.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":503,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, and 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":23942,"source":{"system":"sec-edgar","filing":"0000950170-24-104192","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024104192/ownership.xml","form_type":"4"}},{"id":1414463,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-09-05T23:57:22.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":503,"price":34.26,"value":17232.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on September 3, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, and 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":23439,"source":{"system":"sec-edgar","filing":"0000950170-24-104192","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024104192/ownership.xml","form_type":"4"}},{"id":1414462,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-09-05T23:57:22.000Z","date":"2024-09-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":254,"price":35.3,"value":8966.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The closing price on August 30, 2024 was used to calculate the withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, and 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":22936,"source":{"system":"sec-edgar","filing":"0000950170-24-104192","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024104192/ownership.xml","form_type":"4"}},{"id":1421126,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-08-28T21:59:31.000Z","date":"2024-08-26","kind":"sale","planned":false,"acquired":false,"shares":3101,"price":35.71,"value":110736.71,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, and 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":23190,"source":{"system":"sec-edgar","filing":"0000950170-24-101501","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024101501/ownership.xml","form_type":"4"}},{"id":1460815,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock option (right to buy)","published_at":"2024-07-03T20:54:45.000Z","date":"2024-07-01","kind":"exercise","planned":true,"acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully exercisable."}],"balance_after":25037,"derivative":{"exercise_price":3.29,"expiration_date":"2025-02-18","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0000950170-24-081594","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024081594/ownership.xml","form_type":"4"}},{"id":1460814,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-07-03T20:54:45.000Z","date":"2024-07-01","kind":"sale","planned":true,"acquired":false,"shares":11000,"price":32.49,"value":357390.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction was made pursuant to a 10b5-1 plan in effect at the time of the transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, and 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":26291,"source":{"system":"sec-edgar","filing":"0000950170-24-081594","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024081594/ownership.xml","form_type":"4"}},{"id":1460813,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-07-03T20:54:45.000Z","date":"2024-07-01","kind":"exercise","planned":true,"acquired":true,"shares":11000,"price":3.29,"value":36190.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, and 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":37291,"source":{"system":"sec-edgar","filing":"0000950170-24-081594","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024081594/ownership.xml","form_type":"4"}},{"id":1471204,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-06-24T22:47:51.000Z","date":"2024-06-24","kind":"gift","planned":false,"acquired":true,"shares":550,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Custodial Account for Child"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian."}],"balance_after":9250,"source":{"system":"sec-edgar","filing":"0000950170-24-076962","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024076962/ownership.xml","form_type":"4"}},{"id":1471203,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-06-24T22:47:51.000Z","date":"2024-06-24","kind":"gift","planned":false,"acquired":true,"shares":550,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Custodial Account for Child"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian."}],"balance_after":9250,"source":{"system":"sec-edgar","filing":"0000950170-24-076962","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024076962/ownership.xml","form_type":"4"}},{"id":1471202,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-06-24T22:47:51.000Z","date":"2024-06-24","kind":"gift","planned":false,"acquired":true,"shares":550,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Custodial Account for Child"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian."}],"balance_after":7250,"source":{"system":"sec-edgar","filing":"0000950170-24-076962","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024076962/ownership.xml","form_type":"4"}},{"id":1471201,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-06-24T22:47:51.000Z","date":"2024-06-24","kind":"other","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Custodial Account for Child"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were transferred from the custodial account to the child's personal account."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian."}],"balance_after":6700,"source":{"system":"sec-edgar","filing":"0000950170-24-076962","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024076962/ownership.xml","form_type":"4"}},{"id":1471200,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-06-24T22:47:51.000Z","date":"2024-06-24","kind":"gift","planned":false,"acquired":false,"shares":2650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, and 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":26291,"source":{"system":"sec-edgar","filing":"0000950170-24-076962","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024076962/ownership.xml","form_type":"4"}},{"id":1488824,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock option (right to buy)","published_at":"2024-06-06T22:21:27.000Z","date":"2024-06-04","kind":"exercise","planned":false,"acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully exercisable."}],"balance_after":36037,"derivative":{"exercise_price":3.29,"expiration_date":"2025-02-18","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0000950170-24-070045","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024070045/ownership.xml","form_type":"4"}},{"id":1488823,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-06-06T22:21:27.000Z","date":"2024-06-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":8174,"price":32.87,"value":268679.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability arising from a net (cashless) exercise of options that occurred on June 4, 2024. The options subject to the net exercise were to expire on February 18, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, and 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":28941,"source":{"system":"sec-edgar","filing":"0000950170-24-070045","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024070045/ownership.xml","form_type":"4"}},{"id":1488822,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-06-06T22:21:27.000Z","date":"2024-06-04","kind":"exercise","planned":false,"acquired":true,"shares":14000,"price":3.29,"value":46060.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, and 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":37115,"source":{"system":"sec-edgar","filing":"0000950170-24-070045","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024070045/ownership.xml","form_type":"4"}},{"id":1490727,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-06-06T01:19:38.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":1818,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, and 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":23115,"source":{"system":"sec-edgar","filing":"0000950170-24-069612","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024069612/ownership.xml","form_type":"4"}},{"id":1490726,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-06-06T01:19:38.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":1818,"price":31.3,"value":56903.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on June 3, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, and 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":21297,"source":{"system":"sec-edgar","filing":"0000950170-24-069612","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024069612/ownership.xml","form_type":"4"}},{"id":1490725,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-06-06T01:19:38.000Z","date":"2024-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":724,"price":30.17,"value":21843.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The closing price on May 31, 2024 was used to calculate the withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, and 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":19479,"source":{"system":"sec-edgar","filing":"0000950170-24-069612","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024069612/ownership.xml","form_type":"4"}},{"id":1498358,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock option (right to buy)","published_at":"2024-05-31T01:00:53.000Z","date":"2024-05-28","kind":"exercise","planned":true,"acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."}],"balance_after":50037,"derivative":{"exercise_price":3.29,"expiration_date":"2025-02-18","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0000950170-24-066889","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024066889/ownership.xml","form_type":"4"}},{"id":1498357,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-05-31T01:00:53.000Z","date":"2024-05-28","kind":"sale","planned":true,"acquired":false,"shares":11000,"price":30.3904,"value":334294.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for entire number of shares sold. The actual sale prices range from $29.25 to $32.00. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,091 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, and 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":20203,"source":{"system":"sec-edgar","filing":"0000950170-24-066889","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024066889/ownership.xml","form_type":"4"}},{"id":1498356,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-05-31T01:00:53.000Z","date":"2024-05-28","kind":"exercise","planned":true,"acquired":true,"shares":11000,"price":3.29,"value":36190.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,091 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, and 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":31203,"source":{"system":"sec-edgar","filing":"0000950170-24-066889","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024066889/ownership.xml","form_type":"4"}},{"id":1598842,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-03-06T01:41:18.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,091 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, and 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":20203,"source":{"system":"sec-edgar","filing":"0000950170-24-026707","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024026707/ownership.xml","form_type":"4"}},{"id":1598841,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-03-06T01:41:18.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":697,"price":24.06,"value":16769.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2012 Incentive Award Plan on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,091 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, and 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":19506,"source":{"system":"sec-edgar","filing":"0000950170-24-026707","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024026707/ownership.xml","form_type":"4"}},{"id":1598840,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-03-06T01:41:18.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":656,"price":24.06,"value":15783.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,091 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, and 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":18809,"source":{"system":"sec-edgar","filing":"0000950170-24-026707","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024026707/ownership.xml","form_type":"4"}},{"id":1647145,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock option (right to buy)","published_at":"2024-02-14T00:38:46.000Z","date":"2024-02-09","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable ratably in equal installments on each monthly anniversary of February 9, 2024 over a four-year period."}],"balance_after":200000,"derivative":{"exercise_price":23.01,"expiration_date":"2034-02-09","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000950170-24-014853","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024014853/ownership.xml","form_type":"4"}},{"id":1650016,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-02-13T01:12:04.000Z","date":"2023-02-22","kind":"gift","planned":false,"acquired":false,"shares":1175,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,600 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 2,091 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, and 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":19465,"source":{"system":"sec-edgar","filing":"0000950170-24-014085","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024014085/ownership.xml","form_type":"5"}}],"next_cursor":"2024-02-13T01:12:04.000000Z,1650016"}